Chromogranins as diagnostic and prognostic markers in neuroendocrine tumours

Advances in Experimental Medicine and Biology

Volumn 482, Issue , 2000, Pages 329-337

  Oberg K ^a   Stridsberg, M ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A; TUMOR MARKER;

ADRENAL CORTEX CELL; CANCER LOCALIZATION; CONFERENCE PAPER; ENDOCRINE CELL; ENTEROCHROMAFFIN CELL; IMMUNOHISTOCHEMISTRY; MULTIPLE ENDOCRINE NEOPLASIA; NEUROENDOCRINE SYSTEM; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RADIOIMMUNOASSAY;

CHROMOGRANINS; HUMANS; IMMUNOHISTOCHEMISTRY; NEUROENDOCRINE TUMORS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034472078     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (33)

1. Chromogranin A, neuronspecific enolase, carcinoembryonic antigen and hydroxi indole acetic acid evaluation in patients with neuroendocrine tumors
2. Fundic argyrophil cell hyperplasia in atrophic gastritis: A search for a sensitive diagnostic method
3. Three-step immunoscintigraphy with anti-chromogranin A monoclonal antibody in tumours of the pituitary region
4. Plasma chromogranin A as marker of sympathochromaffin activity in humans
5. Quantitative ultrastructure of endocrine cells of oxyntic mucosa in Zollinger-Ellison syndrome
6. Chromogranin A, its role in endocrine function and as an endocrine and neuroendocrine tumor marker
7. Distinct patterns of chromogranin A-related species can be demonstrated in endocrine cells
8. Immunoassay and immunohistology studies of chromogranin A as a neuroendocrine marker in patients with carcinoma of the prostate
9. Chromogranin A concentrations in plasma of physically active men after acute exercise
10. A polyclonal antiserum against chromogranin a and B - A new sensitive marker for neuroendocrine tumours
11. Immunohistochemical evaluation of neuroendocrine cells and neoplasms of the lung
12. Plasma chromogranin A in patients with multiple endocrine neoplasia type 1
13. Endocrine cells and prognosis in patients with colorectal carcinoma
14. Chromogranin A in familial pheochromocytoma: Diagnostic screening value, prediction of tumor mass, and post-resection kinetics indicating two-compartment distribution
15. Chromogranin A: Current status as a precursor for bioactive peptides and a granulogenic/sorting factor in the regulated secretory pathway
16. Carcinoid tumors. Analysis of prognostic factors and survival in 301 patients from a referral center
17. Elevated plasma chromogranin-A concentrations in prostatic carcinoma
18. Antiserum directed against chromogranin A and B (CAB) is a useful marker for peptide hormone-producing endocrine cells and tumors
19. Chromogranin A as serum marker for neuroendocrine neoplasia: Comparison with neuron-specific enolase and the α-subunit of glycoprotein hormones
20. Serum chromogranin A in the differential diagnosis of Cushing's syndrome
21. Immunoreactive chromogranin A in diverse polypeptide hormone producing tumors and normal endocrine tissues
22. Endocrine aspects of exocrine cancer of the pancreas. Their patterns and suggested biologic significance
23. Serum gastrin and chromogranin A during meal
24. Source of plasma Chromogranin-A elevation in gastrinoma patients
25. Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours
26. Chromogranin A and chromogranin B are sensitive circulating markers for pheochromocytoma
27. Neuroendocrine differentiation and clinical behaviour in non-small cell lung tumors
28. Chromogranin A and pancreastatin-like immunoreactivity in serum of gastrinoma patients
29. Neuroendocrine differentiation in colorectal carcinomas
30. Neuroendocrine sources of chromogranin-A in normal man: Clues from selective stimulation of endocrine glands
31. Plasma levels of chromogranin A are directly proportional to tumour burden in neuroblastoma
32. Synaptophysin and chromogranins/secretogranins - Widespread constutuents of distinct types of neuroendocrine vesicles and new tools in tumor diagnosis
33. The chromogranins A and B, the first 25 years and future perspectives